{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:56:41Z","timestamp":1772827001335,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.4065\/84.1.43","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T22:49:32Z","timestamp":1232750972000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Secondary Prevention of Atherothrombotic Events After Ischemic Stroke"],"prefix":"10.4065","volume":"84","author":[{"suffix":"Jr","given":"Harold P.","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.4065\/84.1.43_bib1","first-page":"e25","article-title":"Heart disease and stroke statistics\u20142008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"issue":"5 (suppl)","key":"10.4065\/84.1.43_bib2","doi-asserted-by":"crossref","first-page":"683S","DOI":"10.1378\/chest.114.5_Supplement.683S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke","volume":"114","author":"Albers","year":"1998","journal-title":"Chest"},{"issue":"11","key":"10.4065\/84.1.43_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.4065\/84.1.43_bib4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/STROKEAHA.106.481465","article-title":"Readmission and death after hospitalization for acute ischemic stroke: 5-year follow-up in the Medicare population","volume":"38","author":"Bravata","year":"2007","journal-title":"Stroke"},{"issue":"1","key":"10.4065\/84.1.43_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/euhj.2000.2226","article-title":"The interrelation between carotid, femoral and coronary artery disease [editorial]","volume":"22","author":"Rothwell","year":"2001","journal-title":"Eur Heart J"},{"issue":"10","key":"10.4065\/84.1.43_bib6","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000090444.87006.CF","volume":"108","author":"Adams","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.4065\/84.1.43_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ncpneuro0352","article-title":"Secondary prevention measures after a stroke\u2014should they target stroke or heart disease?","volume":"2","author":"Fayad","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"issue":"10","key":"10.4065\/84.1.43_bib8","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2006.04.026","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.4065\/84.1.43_bib9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/STROKEAHA.107.189063","article-title":"Update to the AHA\/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke"},{"issue":"2","key":"10.4065\/84.1.43_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"issue":"3 (suppl)","key":"10.4065\/84.1.43_bib11","doi-asserted-by":"crossref","first-page":"483S","DOI":"10.1378\/chest.126.3_suppl.483S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thombolytic Therapy","volume":"126","author":"Albers","year":"2004","journal-title":"Chest"},{"issue":"3\u20134","key":"10.4065\/84.1.43_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10641960600549405","article-title":"Arterial hypertension and stroke prevention: an update","volume":"28","author":"Bornstein","year":"2006","journal-title":"Clin Exp Hypertens"},{"issue":"10","key":"10.4065\/84.1.43_bib13","first-page":"S5","article-title":"Blood pressure, antihypertensive treatment and stroke risk","volume":"12","author":"MacMahon","year":"1994","journal-title":"J Hypertens Suppl"},{"issue":"2","key":"10.4065\/84.1.43_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.25.2.155","article-title":"Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective","volume":"25","author":"Alexander","year":"1995","journal-title":"Hypertension"},{"issue":"2","key":"10.4065\/84.1.43_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.STR.0000109769.22917.B0","article-title":"Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome","volume":"35","author":"Castillo","year":"2004","journal-title":"Stroke"},{"issue":"10","key":"10.4065\/84.1.43_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1474-4422(03)00525-8","article-title":"The management of blood pressure in acute stroke","volume":"2","author":"Chalmers","year":"2003","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.4065\/84.1.43_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.0000113297.76013.51","article-title":"Blood pressure management in patients with acute ischemic stroke [published correction appears in Hypertension. 2004;43 (5):e35]","volume":"43","author":"Goldstein","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"10.4065\/84.1.43_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.hjh.0000160224.94220.e7","article-title":"CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) pilot trial: rationale and design","volume":"23","author":"CHHIPS Trial Group","year":"2005","journal-title":"J Hypertens"},{"issue":"7","key":"10.4065\/84.1.43_bib19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"issue":"4","key":"10.4065\/84.1.43_bib20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","article-title":"Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association","volume":"34","author":"Adams","year":"2003","journal-title":"Stroke"},{"issue":"4","key":"10.4065\/84.1.43_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.STR.0000126208.14181.DD","article-title":"Blood pressure and stroke: an overview of published reviews [published correction appears in Stroke. 2004;35 (3):776-785]","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"issue":"11","key":"10.4065\/84.1.43_bib22","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review","volume":"34","author":"Rashid","year":"2003","journal-title":"Stroke"},{"issue":"9395","key":"10.4065\/84.1.43_bib23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure lowering regiments on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.4065\/84.1.43_bib24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"suppl 1","key":"10.4065\/84.1.43_bib25","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00005344-200109011-00004","article-title":"Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events","volume":"37","author":"Enseleit","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.4065\/84.1.43_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.STR.0000115162.16321.AA","article-title":"Hypertension, angiotensin, and stroke: beyond blood pressure","volume":"35","author":"Iadecola","year":"2004","journal-title":"Stroke"},{"issue":"9287","key":"10.4065\/84.1.43_bib27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.4065\/84.1.43_bib28","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1345\/aph.1K280","article-title":"Impact of statins on risk of stroke: a meta-analysis","volume":"41","author":"Henyan","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.4065\/84.1.43_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"issue":"9411","key":"10.4065\/84.1.43_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","article-title":"Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions","volume":"363","author":"Collins","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.4065\/84.1.43_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0021-9150(98)00014-8","article-title":"HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data","volume":"138","author":"Crouse","year":"1998","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.4065\/84.1.43_bib32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/156720207782446333","article-title":"Macrophage infiltration, lectin-like oxidized-LDL receptor-1, and monoctye chemoattractant protein-1 are reduced by chronic HMG-CoA reductase inhibition","volume":"4","author":"Tsuchiya","year":"2007","journal-title":"Curr Neurovasc Res"},{"issue":"5","key":"10.4065\/84.1.43_bib33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00005344-199805000-00017","article-title":"Direct effects of statins on the vascular wall","volume":"31","author":"Corsini","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"10.4065\/84.1.43_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1212\/01.wnl.0000252799.64165.d5","article-title":"Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis [published correction appears in Neurology. 2007;68 (18):1547]","volume":"68","author":"Bang","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.4065\/84.1.43_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/01.wnl.0000258538.06950.a1","article-title":"Low LDL cholesterol, statins, and brain hemorrhage: should we worry [editorial]?","volume":"68","author":"Goldstein","year":"2007","journal-title":"Neurology"},{"issue":"23","key":"10.4065\/84.1.43_bib36","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/01.CIR.103.23.2828","article-title":"Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)","volume":"103","author":"Bloomfield Rubins","year":"2001","journal-title":"Circulation"},{"issue":"10","key":"10.4065\/84.1.43_bib37","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0002-9149(02)02774-1","article-title":"Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia","volume":"90","author":"Gagn\u00e9","year":"2002","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.4065\/84.1.43_bib38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4065\/78.6.735","article-title":"Niacin as a component of combination therapy for dyslipidemia","volume":"78","author":"Miller","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.4065\/84.1.43_bib39","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/01.STR.0000072985.24967.7F","article-title":"Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register","volume":"34","author":"Hillen","year":"2003","journal-title":"Stroke"},{"issue":"1","key":"10.4065\/84.1.43_bib40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.50.1.208","article-title":"Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989","volume":"50","author":"Petty","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.4065\/84.1.43_bib41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/WNL.59.6.809","article-title":"Insulin resistance and risk for stroke","volume":"59","author":"Kernan","year":"2002","journal-title":"Neurology"},{"issue":"19","key":"10.4065\/84.1.43_bib42","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"10.4065\/84.1.43_bib43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199307293290502","article-title":"The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus","volume":"329","author":"Reichard","year":"1993","journal-title":"N Engl J Med"},{"issue":"9374","key":"10.4065\/84.1.43_bib44","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.4065\/84.1.43_bib45","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)","volume":"20","author":"Py\u00f4r\u00e4l\u00e4","year":"1997","journal-title":"Diabetes Care"},{"issue":"23","key":"10.4065\/84.1.43_bib46","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension","volume":"276","author":"Curb","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.4065\/84.1.43_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/84.1.43_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.1993.03500020066033","article-title":"Smoking cessation and decreased risk of stroke in women","volume":"269","author":"Kawachi","year":"1993","journal-title":"JAMA"},{"issue":"7","key":"10.4065\/84.1.43_bib49","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.1988.03720070025028","article-title":"Cigarette smoking as a risk factor for stroke: the Framingham Study","volume":"259","author":"Wolf","year":"1988","journal-title":"JAMA"},{"issue":"4","key":"10.4065\/84.1.43_bib50","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2105\/AJPH.89.4.572","article-title":"Ischemic stroke risk and passive exposure to spouses' cigarette smoking","volume":"89","author":"You","year":"1999","journal-title":"Am J Public Health"},{"issue":"2 (suppl 1)","key":"10.4065\/84.1.43_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1520-037X.2007.05992.x","article-title":"Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions","volume":"10","author":"Nides","year":"2007","journal-title":"Prev Cardiol"},{"issue":"3","key":"10.4065\/84.1.43_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"issue":"17","key":"10.4065\/84.1.43_bib53","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"Viscoli","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/84.1.43_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1474-4422(06)70685-8","article-title":"Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial","volume":"6","author":"ESPRIT Study Group","year":"2007","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.4065\/84.1.43_bib55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.STR.0000047035.04395.ED","article-title":"Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin","volume":"34","author":"Algra","year":"2003","journal-title":"Stroke"},{"issue":"13","key":"10.4065\/84.1.43_bib56","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"Chimowitz","year":"2005","journal-title":"N Engl J Med"},{"issue":"20","key":"10.4065\/84.1.43_bib57","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"},{"issue":"7329","key":"10.4065\/84.1.43_bib58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"18","key":"10.4065\/84.1.43_bib59","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","author":"Dutch TIA Trial Study Group","year":"1991","journal-title":"N Engl J Med"},{"issue":"8779","key":"10.4065\/84.1.43_bib60","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events","volume":"338","author":"SALT Collaborative Group","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.4065\/84.1.43_bib61","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.STR.19.4.436","article-title":"Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials","volume":"19","author":"Sze","year":"1988","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.4065\/84.1.43_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"issue":"9523","key":"10.4065\/84.1.43_bib63","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"ESPRIT Study Group","year":"2006","journal-title":"Lancet"},{"issue":"8649","key":"10.4065\/84.1.43_bib64","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"1","author":"Gent","year":"1989","journal-title":"Lancet"},{"issue":"8","key":"10.4065\/84.1.43_bib65","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"issue":"22","key":"10.4065\/84.1.43_bib66","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","article-title":"Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial","volume":"289","author":"Gorelick","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.4065\/84.1.43_bib67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00002018-199921040-00007","article-title":"Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE","volume":"21","author":"Harker","year":"1999","journal-title":"Drug Saf"},{"issue":"2","key":"10.4065\/84.1.43_bib68","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.STR.0000109253.66918.5E","article-title":"Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration","volume":"35","author":"Zakarija","year":"2004","journal-title":"Stroke"},{"issue":"9038","key":"10.4065\/84.1.43_bib69","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"12","key":"10.4065\/84.1.43_bib70","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.4065\/84.1.43_bib71","first-page":"e148","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.4065\/84.1.43_bib72","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","volume":"117","author":"Antman","year":"2008","journal-title":"Circulation"},{"issue":"9431","key":"10.4065\/84.1.43_bib73","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"16","key":"10.4065\/84.1.43_bib74","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"issue":"19","key":"10.4065\/84.1.43_bib75","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.4065\/84.1.43_bib76","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial","volume":"111","author":"Markus","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.4065\/84.1.43_bib77","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.4065\/84.1.43_bib78","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","author":"North American Symptomatic Carotid Endarterectomy Trial Collaborators","year":"1991","journal-title":"N Engl J Med"},{"issue":"9113","key":"10.4065\/84.1.43_bib79","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(97)09292-1","article-title":"Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"19","key":"10.4065\/84.1.43_bib80","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJM198511073131904","article-title":"Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial","volume":"313","author":"EC\/IC Bypass Study Group","year":"1985","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/84.1.43_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11910-004-0007-7","article-title":"Extracranial-intracranial arterial bypass for treatment of occlusion of the internal carotid artery","volume":"4","author":"Grubb","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9543","key":"10.4065\/84.1.43_bib82","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(06)69122-8","article-title":"30 Day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial","volume":"368","author":"SPACE Collaborative Group","year":"2006","journal-title":"Lancet"},{"issue":"16","key":"10.4065\/84.1.43_bib83","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa061752","article-title":"Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis","volume":"355","author":"Mas","year":"2006","journal-title":"N Engl J Med"},{"issue":"15","key":"10.4065\/84.1.43_bib84","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa040127","article-title":"Protected carotid-artery stenting versus endarterectomy in high-risk patients","volume":"351","author":"Yadav","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.4065\/84.1.43_bib85","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3171\/jns.1999.91.4.0547","article-title":"Extracranial vertebral artery stent placement: in-hospital and follow-up results","volume":"91","author":"Chastain","year":"1999","journal-title":"J Neurosurg"},{"issue":"1","key":"10.4065\/84.1.43_bib86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1148\/radiol.2311030183","article-title":"Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents\u2014initial experience","volume":"231","author":"de Rochemont Rdu","year":"2004","journal-title":"Radiology"},{"issue":"10","key":"10.4065\/84.1.43_bib87","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/01.STR.30.10.2073","article-title":"Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement","volume":"30","author":"Malek","year":"1999","journal-title":"Stroke"},{"issue":"5","key":"10.4065\/84.1.43_bib88","first-page":"787","article-title":"Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis","volume":"20","author":"Mori","year":"1999","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611608070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611608070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:43:17Z","timestamp":1706002997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611608070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0025619611608070"],"URL":"https:\/\/doi.org\/10.4065\/84.1.43","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary Prevention of Atherothrombotic Events After Ischemic Stroke","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/84.1.43","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}